Martine A. Rothblatt's Insider Trades & SAST Disclosures
Martine A. Rothblatt's most recent trade in United Therapeutics Corp was a trade of 229,947 Common Stock done . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Martine A. Rothblatt.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Mar 2025 | 229,947 | 258,117 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Mar 2025 | 229,947 | 15,962 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2024 | 269 | 0 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 26 Aug 2024 | 269 | 399 (0%) | 0% | 129.5 | 34,833 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 348.20 per share. | 26 Aug 2024 | 196 | 175 (0%) | 0% | 348.2 | 68,247 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 347.29 per share. | 26 Aug 2024 | 28 | 371 (0%) | 0% | 347.3 | 9,724 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 350.87 per share. | 26 Aug 2024 | 23 | 130 (0%) | 0% | 350.9 | 8,070 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 349.23 per share. | 26 Aug 2024 | 22 | 153 (0%) | 0% | 349.2 | 7,683 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2024 | 3,600 | 7,469 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2024 | 3,600 | 3,869 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 22 Aug 2024 | 3,600 | 3,730 (0%) | 0% | 129.5 | 466,164 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 22 Aug 2024 | 3,600 | 3,730 (0%) | 0% | 129.5 | 466,164 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 348.19 per share. | 22 Aug 2024 | 2,306 | 801 (0%) | 0% | 348.2 | 802,926 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 346.43 per share. | 22 Aug 2024 | 1,226 | 1,785 (0%) | 0% | 346.4 | 424,720 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 347.20 per share. | 22 Aug 2024 | 1,148 | 637 (0%) | 0% | 347.2 | 398,581 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 345.53 per share. | 22 Aug 2024 | 719 | 3,011 (0%) | 0% | 345.5 | 248,439 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 349.14 per share. | 22 Aug 2024 | 671 | 130 (0%) | 0% | 349.1 | 234,271 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 347.07 per share. | 22 Aug 2024 | 478 | 3,107 (0%) | 0% | 347.1 | 165,900 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 348.23 per share. | 22 Aug 2024 | 373 | 264 (0%) | 0% | 348.2 | 129,891 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 345.52 per share. | 22 Aug 2024 | 145 | 3,585 (0%) | 0% | 345.5 | 50,101 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 349.88 per share. | 22 Aug 2024 | 98 | 166 (0%) | 0% | 349.9 | 34,288 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 351.33 per share. | 22 Aug 2024 | 36 | 130 (0%) | 0% | 351.3 | 12,648 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 20 Aug 2024 | 3,600 | 3,730 (0%) | 0% | 129.5 | 466,164 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 20 Aug 2024 | 3,600 | 3,730 (0%) | 0% | 129.5 | 466,164 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 3,600 | 11,069 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 3,600 | 14,669 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 352.57 per share. | 20 Aug 2024 | 1,164 | 201 (0%) | 0% | 352.6 | 410,388 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 341.76 per share. | 20 Aug 2024 | 946 | 2,784 (0%) | 0% | 341.8 | 323,307 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 347.91 per share. | 20 Aug 2024 | 837 | 2,553 (0%) | 0% | 347.9 | 291,202 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 348.22 per share. | 20 Aug 2024 | 660 | 764 (0%) | 0% | 348.2 | 229,828 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 347.48 per share. | 20 Aug 2024 | 640 | 1,424 (0%) | 0% | 347.5 | 222,384 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 351.47 per share. | 20 Aug 2024 | 459 | 1,365 (0%) | 0% | 351.5 | 161,323 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 350.10 per share. | 20 Aug 2024 | 390 | 1,824 (0%) | 0% | 350.1 | 136,538 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 343.10 per share. | 20 Aug 2024 | 362 | 2,422 (0%) | 0% | 343.1 | 124,202 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 346.34 per share. | 20 Aug 2024 | 340 | 3,390 (0%) | 0% | 346.3 | 117,755 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 348.76 per share. | 20 Aug 2024 | 339 | 2,214 (0%) | 0% | 348.8 | 118,229 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 350.61 per share. | 20 Aug 2024 | 237 | 376 (0%) | 0% | 350.6 | 83,095 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 345.66 per share. | 20 Aug 2024 | 220 | 2,064 (0%) | 0% | 345.7 | 76,045 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 351.82 per share. | 20 Aug 2024 | 173 | 203 (0%) | 0% | 351.8 | 60,864 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 349.47 per share. | 20 Aug 2024 | 151 | 613 (0%) | 0% | 349.5 | 52,770 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 343.64 per share. | 20 Aug 2024 | 138 | 2,284 (0%) | 0% | 343.6 | 47,422 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 353.16 per share. | 20 Aug 2024 | 73 | 130 (0%) | 0% | 353.2 | 25,781 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 352.99 per share. | 20 Aug 2024 | 71 | 130 (0%) | 0% | 353.0 | 25,062 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 19 Aug 2024 | 3,600 | 3,730 (0%) | 0% | 129.5 | 466,164 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 3,600 | 14,669 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 348.86 per share. | 19 Aug 2024 | 808 | 178 (0%) | 0% | 348.9 | 281,881 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 348.23 per share. | 19 Aug 2024 | 639 | 986 (0%) | 0% | 348.2 | 222,517 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 346.89 per share. | 19 Aug 2024 | 413 | 1,625 (0%) | 0% | 346.9 | 143,264 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 337.99 per share. | 19 Aug 2024 | 285 | 3,038 (0%) | 0% | 338.0 | 96,327 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 339.35 per share. | 19 Aug 2024 | 256 | 2,782 (0%) | 0% | 339.4 | 86,874 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 345.74 per share. | 19 Aug 2024 | 219 | 2,038 (0%) | 0% | 345.7 | 75,717 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 343.80 per share. | 19 Aug 2024 | 205 | 2,384 (0%) | 0% | 343.8 | 70,478 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 339.93 per share. | 19 Aug 2024 | 152 | 2,630 (0%) | 0% | 339.9 | 51,670 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 344.70 per share. | 19 Aug 2024 | 127 | 2,257 (0%) | 0% | 344.7 | 43,777 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 335.84 per share. | 19 Aug 2024 | 118 | 3,323 (0%) | 0% | 335.8 | 39,629 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 333.11 per share. | 19 Aug 2024 | 96 | 3,519 (0%) | 0% | 333.1 | 31,979 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 331.53 per share. | 19 Aug 2024 | 79 | 3,615 (0%) | 0% | 331.5 | 26,191 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 334.49 per share. | 19 Aug 2024 | 78 | 3,441 (0%) | 0% | 334.5 | 26,090 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 350.33 per share. | 19 Aug 2024 | 48 | 130 (0%) | 0% | 350.3 | 16,816 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 341.32 per share. | 19 Aug 2024 | 41 | 2,589 (0%) | 0% | 341.3 | 13,994 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 329.03 per share. | 19 Aug 2024 | 36 | 3,694 (0%) | 0% | 329.0 | 11,845 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,600 | 18,269 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,600 | 21,869 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 15 Aug 2024 | 3,600 | 3,730 (0%) | 0% | 129.5 | 466,164 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 15 Aug 2024 | 3,600 | 3,730 (0%) | 0% | 129.5 | 466,164 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 320.97 per share. | 15 Aug 2024 | 1,734 | 947 (0%) | 0% | 321.0 | 556,561 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 322.67 per share. | 15 Aug 2024 | 1,084 | 1,821 (0%) | 0% | 322.7 | 349,773 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 323.76 per share. | 15 Aug 2024 | 1,025 | 796 (0%) | 0% | 323.8 | 331,857 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 321.90 per share. | 15 Aug 2024 | 825 | 2,905 (0%) | 0% | 321.9 | 265,564 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 321.92 per share. | 15 Aug 2024 | 660 | 287 (0%) | 0% | 321.9 | 212,468 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 319.99 per share. | 15 Aug 2024 | 613 | 2,681 (0%) | 0% | 320.0 | 196,152 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 317.73 per share. | 15 Aug 2024 | 434 | 3,296 (0%) | 0% | 317.7 | 137,894 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 325.91 per share. | 15 Aug 2024 | 372 | 130 (0%) | 0% | 325.9 | 121,239 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 324.94 per share. | 15 Aug 2024 | 294 | 502 (0%) | 0% | 324.9 | 95,532 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 323.06 per share. | 15 Aug 2024 | 157 | 130 (0%) | 0% | 323.1 | 50,720 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 318.50 per share. | 15 Aug 2024 | 2 | 3,294 (0%) | 0% | 318.5 | 637 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 13 Aug 2024 | 3,600 | 3,730 (0%) | 0% | 129.5 | 466,164 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 13 Aug 2024 | 3,600 | 3,730 (0%) | 0% | 129.5 | 466,164 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 3,600 | 29,069 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 3,600 | 25,469 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 323.79 per share. | 13 Aug 2024 | 1,701 | 1,436 (0%) | 0% | 323.8 | 550,762 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 322.52 per share. | 13 Aug 2024 | 807 | 2,055 (0%) | 0% | 322.5 | 260,272 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 321.61 per share. | 13 Aug 2024 | 725 | 2,862 (0%) | 0% | 321.6 | 233,170 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 323.10 per share. | 13 Aug 2024 | 593 | 3,137 (0%) | 0% | 323.1 | 191,599 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 337.87 per share. | 13 Aug 2024 | 526 | 215 (0%) | 0% | 337.9 | 177,717 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 325.88 per share. | 13 Aug 2024 | 514 | 600 (0%) | 0% | 325.9 | 167,500 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 327.10 per share. | 13 Aug 2024 | 424 | 176 (0%) | 0% | 327.1 | 138,690 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 326.60 per share. | 13 Aug 2024 | 366 | 1,623 (0%) | 0% | 326.6 | 119,537 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 324.76 per share. | 13 Aug 2024 | 322 | 1,114 (0%) | 0% | 324.8 | 104,574 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 336.09 per share. | 13 Aug 2024 | 282 | 741 (0%) | 0% | 336.1 | 94,778 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 334.13 per share. | 13 Aug 2024 | 167 | 1,145 (0%) | 0% | 334.1 | 55,799 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 328.17 per share. | 13 Aug 2024 | 158 | 1,465 (0%) | 0% | 328.2 | 51,851 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 329.73 per share. | 13 Aug 2024 | 153 | 1,312 (0%) | 0% | 329.7 | 50,449 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 319.42 per share. | 13 Aug 2024 | 143 | 3,587 (0%) | 0% | 319.4 | 45,677 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 334.72 per share. | 13 Aug 2024 | 122 | 1,023 (0%) | 0% | 334.7 | 40,836 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 338.49 per share. | 13 Aug 2024 | 85 | 130 (0%) | 0% | 338.5 | 28,772 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 323.71 per share. | 13 Aug 2024 | 66 | 1,989 (0%) | 0% | 323.7 | 21,365 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 327.85 per share. | 13 Aug 2024 | 46 | 130 (0%) | 0% | 327.8 | 15,081 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 3,600 | 36,269 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 3,600 | 32,669 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 09 Aug 2024 | 3,600 | 3,730 (0%) | 0% | 129.5 | 466,164 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges